Evaluation of lentiviral vector-based green fluorescent protein expression in human gastric cancer cell line evaluation of expression lentivirus vector-based GFP in AGS by Saedi-Marghmaleki, Mojtaba et al.
Journal of Shahrekord University of Medical Sciences
© 2019 The Author(s); Published by Shahrekord University of Medical Sciences. This is an open-access article distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and 
reproduction in any medium, provided the original work is properly cited.
2019;21(5):204-209doi:10.15171/jsums.2019.36
Evaluation of lentiviral vector-based green fluorescent 
protein expression in human gastric cancer cell line 
evaluation of expression lentivirus vector-based GFP in AGS
Mojtaba Saedi-Marghmaleki1 ID , Mohammad-Taghi Moradi2, Payam Ghasemi-Dehkordi1, Leyla Hashemi1, Ali Karimi2*
ID
1Cellular and Molecular Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, 
Shahrekord, Iran
2Medical Plants Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran
*Corresponding Author: Ali Karimi Email: rakarimi1342@gmail.com
http://j.skums.ac.ir
Original Article
Abstract
Background and aims:  Human immunodeficiency virus type 1 (HIV-1) based-lentivirus vector is one of the most promising viral vectors 
for gene delivery in different cell lines including gastric cell lines. Therefore, the aim of this study was to produce a lentivirus vector for 
transduction and expression of green fluorescent protein (GFP) in human gastric cancer cell line, AGS.
Materials and Methods: In this piece of work, Escherichia coli HB101 was transformed with plasmids psPAX2, pTD, and pMD2.G, following 
the purification of which their DNA was extracted along with their quantity and quality evaluated to be used in the next experiments. 
Subsequently, to produce the vector, the packaging cells were transfected with the plasmids and the vector containing supernatant was 
collected and purified using ultracentrifuge. ELISA was used to confirm the construction of the vector. Fluorescent microscopy and flow 
cytometry were used to check the expression of GFP in the cell line and to calculate the percentage of GFP expression, respectively. 
Results: In this study, the results of ELISA confirmed the construction of the plasmid used in this study. AGS cells were infected with viruses 
produced to detect the viral activity and GFP expression was evaluated by fluorescence microscopy and flow cytometry after 72 hours. 
Based on the results of flow cytometry, GFP was expressed in over 90% of transduced AGS cells. 
Conclusion: The results of this study showed that lentiviral vector is a highly efficient vector for expression of GFP gene in AGS cell line.
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Introduction 
Different gene delivery methods including microinjection, 
liposomes, and viral vectors are used in gene therapy. Viral 
vectors and in particular lentivirus-based vectors are the 
most efficient ones for expression of the transgene in 
different cell lines (1), which are capable of infecting a 
wide range of dividing and non-dividing cells. This vector 
can enter the desired gene into the host genome and thus 
cause long-term expression of the transgene (2). Several 
studies have shown that lentivirus is one of the tools for 
genetic manipulation in stem cells (3). Today, the use of 
lentiviruses in basic research and clinical trials of gene 
therapy and regenerative technology is considered. Studies 
have shown that transgenes transmitted by the lentivirus 
can be stably expressed in hematopoietic progenitor cells 
and endothelial cells derived from embryonic stem cells 
(4). A lentivirus is an appropriate tool for expressing 
external genes in most mammalian cells. The packaging of 
genetic vector bearing lentiviral constructs allows for the 
efficient transfer of these expression structures and their 
subsequent expression in different cells. This vector can 
be used for various gene therapy and gene modification 
therapies. In addition, lentiviral viruses are widely used in 
basic medical sciences for gene transfer with the goal of 
expressing protein and RNA, for example, shRNA in gene 
silencing. On the other hand, the use of lentiviral viruses 
for vaccine production is under investigation (5).
The lentiviral vector consists of 3 plasmids. The transfer 
vector contains the cis-acting sequences needed to generate 
RNA and pack the virus. The packaging system consists 
of two separate plasmids, (psPAX2 and pMD2.G) with 
transacting Gag-Pol and Rev factors for psPAX2 and the 
envelope virus (VSVG) for pMD2.G. Gag-Pol encodes 
structural proteins, integrase, reverse transcriptase. The Rev 
protein with the RRE sequence in the transmitted plasmid 
increases the viral titer and the unprocessed transfer of 
RNA into the nucleus. To produce lentivirus, the plasmid 
is transfected into HEK-293T cells (genetically engineered 
cells from human embryos). The virus produced by 
exocytosis enters the cellular supernatant, is accumulated 
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in large quantities, and then is used (6).
Gastric cancer is one of the important factors in mortality 
worldwide, which is more prevalent in developing countries 
than in industrial societies (7). Gastric adenocarcinomas 
include 90% of gastric cancer cases and are among the 
deadliest cancers in Iran (8). According to statistics from 
the Cancer Research Center, gastric cancer is the most 
common cancer among Iranian men as well as the third 
most common one among Iranian women after breast and 
colon cancer (9). Histologically, two distinct types of gastric 
adenocarcinoma have been known: intestinal form, which 
produces pseudo-tuberous structures, and a diffuse form 
that has a discohesive nature. The intestinal form typically 
occurs in older people, which causes premature damage and 
spreads to the liver through the blood vessels. The diffuse 
form of gastroduodenal adenocarcinomas occurs in any age 
group. Primary damage is not detected and extends to most 
adjacent tissues. Most gastroduodenal adenocarcinomas are 
identified in the advanced stages; therefore, the mortality 
rate is high (10).
Cancer often occurs when the mechanisms controlling the 
growth and proliferation of the cells are disrupted. It can 
be argued that the cause of all or most of the cancers is a 
defect in cellular regulation (11). Translating cell mRNAs 
and controlling them play a major role in cell growth, 
proliferation, and differentiation (12,13). An AGS cell line 
isolated from the stomach adenocarcinoma of a 54-year-
old Caucasian woman was one of these types of cells (14). 
In this study, the efficacy of lentiviral vector containing the 
green fluorescent gene for expression in AGS cell line of 
human stomach cancer was evaluated.
Materials and Methods
Cells and cell culture
Human gastric cancer cell line AGS and Human Embryonic 
Kidney 293T cells were purchased from the Royan Institute 
of Tehran. Dulbecco’s modified Eagle’s medium (DMEM) 
with 10% FBS and 1% penicillin-streptomycin (Gibco, 
Life Technologies, USA) was used to culture the cells (15). 
Cells were cultured in a T25 flask with DMEM medium 
containing 10% FBS and 1% penicillin-streptomycin 
under standard incubation conditions (37°C, 5% CO2, 
and 98% moisture). The cells were passaged once per week 
using Trypsin and kept in logarithmic phase (16).
Transformation and plasmid purification
The vector carrying the GFP gene and the two auxiliary 
vectors for cloning separately into E. coli HB101 were made 
and plasmids were extracted according to the protocol. 
Three vectors prepared for the production of the virus 
were introduced into a packaging cell line simultaneously 
with calcium phosphate transfection into HEK-293T 
cells (isolated from human embryos). In this study, two 
packaging plasmids called pMD2.G and psPAX2 were 
used.
Production of lentiviral vector
HEK-293T cells are cells isolated from human embryos, 
which are used as a cell line for packaging for the production 
of lentiviruses.
Preparation of lentiviruses containing GFP gene using 
calcium phosphate sedimentation method
To prepare the lentivirus cells and transfer them to target 
cells, HBS (2X) and CaCl2 (2.5 M) buffers were used.
Transfection steps are as follows:
1. A total of 1×106 HEK-293T cells were placed in a 
15 cm2 plate containing 10% DMEM medium and 
incubated at 37°C in an incubator containing CO2.
2. After the cell density reached 80%, the medium was 
replaced with the cell with a serum-free DMEM 
medium and incubated for 2 hours in an incubator 
containing CO2 at 37°C.
3. The transfection solution containing three plasmids 
pTD, psPAX 2, and pMD2.G with concentrations of 
22 μg, 15 μg, and 8 μg was mixed with 115 μL of 
CaCl2 (2.5 M) and distilled water with a volume of 
550 μL for 30 minutes in a 15-mL Falcon tube and 
then was placed in the dark at room temperature.
4. 500 μL of HBS 2X buffer was added to the solution 
and placed at room temperature for 5 minutes. Then, 
it was added drop by drop to the plate containing 
HEK-293T cells.
5. After 24 hours, the medium was replaced with cells 
with a new 10% serum DMEM. 
6. On two occasions, after 48 and 72 hours, the medium 
was collected and then filtered with a 0.45 μm pore 
filter and ultrasound centrifugation was performed at 
40000 rpm for 1.5 hours.
Confirmation of virus production using ELISA
HIV Diagnostic kit (DIA.PRO, Italy) was used according 
to the protocol for confirmation of virus production.
Viral concentration using ultracentrifuge
1. The medium was packed on transfected HEK-293T 
cells containing viruses produced by cells within 48-72 
hours after transfection.
2. To isolate HEK-293T cells simultaneously with the 
removal of the medium, centrifugation was performed 
at 1200 rpm for 5 minutes.
3. After centrifugation, the medium was collected and 
then filtered with a 0.45 μm pore filter and ultrasound 
centrifugation was performed at 40000 rpm for 1.5 
hours.
4. After the centrifugation was completed, the culture 
medium was removed under the hood, and then 
1 mL of the fresh medium was added to the viral 
sediment. The concentrated viruses were then used for 
transduction of the target cells.
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Transduction of AGS cells
1. A total of 5×105 AGS cells were added to each well of 
a 6-well plate and placed overnight in a Co2 incubator 
at 37°C.
2. After the cell density reached 80%, 200 μL of the virus 
produced was added to the AGS and then cultured and 
incubated at 37°C for 8-12 hours in a CO2 incubator.
3. After changing the culture medium on AGS cells, 2 
mL of 10% serum DMEM was added to each well.
4. For 3 days, the culture medium was replaced with 
cells and GFP expression was evaluated using a Nikon 
Multizoom AZ100 multi-purpose microscope.
1. After fluorescence microscopy, the cells were evaluated 
by flow cytometry to confirm the GFP gene expression 
in the cells.
Results
Preparation of lentiviruses containing GFP gene
The supernatant of HEK-293T cells was collected 48 and 
72 hours after transfection. After initial confirmation of 
virus production by ELISA, the viruses were condensed 
with an ultracentrifuge and prepared for transduction. 
Figure 1 shows the production of the virus within 72 hours 
of transfection.???
Transduction of AGS cells with viruses containing GFP 
gene
AGS cells were infected with produced viruses to detect 
the viral activity and GFP expression was evaluated by 
fluorescence microscopy and flow cytometry after 72 hours. 
Figure 2 shows that the pTD-GFP lentivirus has promoted 
the expression of the GFP gene in AGS cells, indicating the 
successful performance of the virus in gene transfer. With 
these two methods, it was found that more than 90% of the 
AGS cells expressed the GFP gene.
Results obtained from flow cytometry
AGS cells were infected with produced viruses and GFP 
expression was evaluated by flow cytometry after 72 hours. 
The pTD-GFP lentiviral vector promoted the expression of 
the GFP gene in AGS cells, which indicates the successful 
performance of the virus in gene transfer. More than 90% 
of the AGS cells expressed the GFP gene. Figure 3 shows 
the control AGS cells that were not infected with the vector 
and thus did not express the GFP gene. Figure 4 shows 
the AGS cells that were infected with the vector and thus 
expressed the GFP gene.
Discussion
Several different methods have been used to transfer the 
therapeutic gene. The selection of an appropriate vector 
for effective expression of the gene in stem cells and its 
progenitor cells is of great importance (1). Several viral 
vectors including retroviruses, adenoviruses, herpes viruses, 
and lentiviruses have been used for this purpose. Studies 
have shown that the recent vector made up of type 1 human 
immunodeficiency virus, which is capable of infecting a 
wide range of dividing and non-dividing cells, is one of 
the best carriers for gene transfer. This vector can enter the 
desired gene into the host genome, thereby causing long-
term expression of the transgene (2,3).
Gastric cancer is the second most common cancer in the 
world, which is in fact one of the main causes of cancer 
deaths. It is estimated that 900 000 new cases are diagnosed 
each year. Gastric cancer is one of the important factors in 
mortality worldwide, which is more prevalent in developing 
countries than in industrial societies (7). In this study, 
after the construction of the vector lentivirus, which was 
performed using pTD, psPAX 2, and pMD2.G plasmids, 
transfection of them in HEK-293T cells was performed. 
The structure was also confirmed using the ELISA method 
(standard protocol). The fluorescence microscopy showed 
that the vector expressed the GFP marker in the AGS cell 
line. Moreover, based on flow cytometric results, this vector 
caused the expression of the GFP gene in more than 90% 
of AGS cells, indicating the acceptable function of the 
vector in transmitting this gene.
In 2010, Jiang et al showed that transgenes transmitted 
by lentivirus can be stably expressed in hematopoietic 
progenitor cells and endothelial progenitor cells derived 
from embryonic stem cells using lentiviruses in fundamental 
research, clinical trials of gene therapy, and regenerative 
Figure 1. GFP gene expression 72 hours after transfection in HEK-293T cells. Image a of HEK-293T cells is observed using fluorescence 
microscopy. Image b of the same cells is observed using a bright field microscope.
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Figure 2. AGS Cells Transduced with pTD-GFP Lentiviral Vector After 72 Hours. Images a and c of AGS transduced cells are observed using 
fluorescence microscopy. Images b and d of the same cells are observed using a bright field microscope.
a b
c d
Figure 3. The Results obtained from flow cytometry for the control sample.
Figure 4. The results obtained from flow cytometry of AGS cells expressing the GFP gene.
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technology (4). This is largely in line with the results of this 
study. Moreover, Zhang et al used lentiviruses in 2010 to 
kill cancer cells. Expressing high levels of HER-2, prostatic 
cancer cells, are resistant to monoclonal antibodies. They 
showed that the lentiviruses with envelope proteins 
destroyed the resistant prostate cancer cells by binding to 
the therapeutic antibody (17). In 2011, Balaggan and Ali 
used lentivirus in ocular diseases and transmitted the gene 
into retina cells (18).
In 2011, Varma et al used hematopoietic stem cells for 
gene therapy. In this method, lentivirus is used to transfer 
the gene to these cells. In a therapeutic genetic study, 
a lentiviral vector containing this gene was transmitted 
to cord blood-derived stem cells, where these cell lines 
were able to express this gene for a long time (19). The 
results of a study by Allahbakhshian-Farsani et al in 2014 
indicated successful production of TetO-FUW-OSKM 
lentiviral vector. The efficacy of gene-transfer method using 
lentiviruses and appropriate expression of transcription 
factors in HDF cells were examined after transduction (20). 
Nasri et al conducted a study in which they transmitted 
GFP gene to CHO, Jurkat, HepG2, MCF-7, and MEF 
cells using lentiviral vector. The gene expression was 
observed in about 96% of the cells (21). In 2012, Liu et al 
proved that lentiviral vector is a good tool for transferring 
SiRNA and silencing genes (22).
In studies that focused on transferring siRNA to gastric 
(23-27), liver (28), and lung (29) cancer cells, the basis for 
the transfer of siRNA from the lentivirus was to induce 
apoptosis. The study we conducted was a preliminary 
and one in which we were looking at how to measure the 
transduction and expression of the GFP gene in AGS cells. 
The results of this study showed high level of transduction, 
and the expression of the GFP gene in AGS cells was more 
than 90%. This study would help us design a research 
project that induces the transfer of siRNA from apoptosis 
to lentiviruses in AGS cells. However, further studies in this 
regard are required.
Taking together the above-mentioned studies as well 
as the current one, it can be concluded that the use of 
the lentiviral vector for gene transfer to most cell lines is 
possible, but more studies are needed. This study also helps 
future studies on the application of lentivirus for shRNA 
transfer to change the expression of genes involved in the 
development of gastric cancer.
Conclusion
What is certain today is that cancer is a worldwide 
disease, and unfortunately most cancers do not have a 
good prognosis. Such studies have led to an increase in 
information on ways of transferring the gene to cancer 
cells. As we can increase the efficiency of the gene transfer 
by lentiviruses, we could improve the therapies. Based on 
the results of this study as well as those of the other studies 
conducted in this field, it can be concluded that the use 
of lentiviral vector is possible for the transfer of various 
genes and shRNAs to most cell lines, but, further studies 
are required.
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